- Just among U.S. adults with employer insurance, non-surgical hemorrhoid treatment costs at least US$770 million annually, suggests a study that concludes this common complaint needs more attention.
Sandler and colleagues looked at insurance claims in 2014 in a database that covered nearly 19 million patients, ages 18 to 64, with employer-provided prescription coverage. The researchers identified patients whose primary reason for a medical visit was hemorrhoids and who received outpatient treatments, such as rubber band ligation or sclerotherapy, or prescription medications such as hydrocortisone.
These estimates don't include over-the-counter treatments for hemorrhoids. The authors note that those expenditures are likely considerable, too, given that worldwide sales of just one brand, Preparation H, hit US$136 million in 2017.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »